Form 4: Artivion CEO Sells Shares for Tax Obligations

Artivion, Inc. President and CEO James P. Mackin sold 34,210 shares of common stock at $45.858 per share to cover tax withholding obligations related to RSU vesting.

Summary

• James P. Mackin, President & CEO of Artivion, Inc. (AORT), reported a sale of common stock.
• The transaction involved the disposition of 34,210 shares of Artivion common stock.
• The shares were sold at a price of $45.858 per share.
• The sale was executed on November 13, 2025, as a pre-planned transaction under a Rule 10b5-1 plan.
• The purpose of the sale was to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs).
• This was a "sell to cover" transaction and explicitly stated as not representing a discretionary sale by the CEO.
• Following this transaction, James P. Mackin beneficially owns 800,993 shares of Artivion, Inc. common stock.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary 'sell to cover' for tax obligations, which is a neutral event. It does not indicate a positive or negative sentiment towards the company's future performance.

Positives

• The transaction is non-discretionary, indicating it is not a voluntary sale driven by a negative outlook on the company's future performance.
• The sale is a standard procedure for covering tax liabilities associated with the vesting of restricted stock units.

Negatives

• A reduction in direct insider ownership, even if non-discretionary, slightly decreases the alignment of the CEO's direct equity holdings with shareholders.

Future Outlook

NA

Industry Context

This is a routine insider transaction (sell-to-cover) common across all industries for executives receiving equity compensation, and does not reflect specific industry trends for medical devices.

Stakeholder Impact

• Shareholders: Minimal impact. A slight reduction in the CEO's direct holdings, but it is a non-discretionary sale for tax purposes, not a signal of lack of confidence in the company.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary "sell to cover" transaction by the CEO to satisfy tax obligations upon RSU vesting. Such sales are common and do not typically signal a change in management's outlook or the company's fundamentals. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Artivion, AORT, James P. Mackin, CEO, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Sell to Cover, Corporate Governance